The point-of-care (POC) market for drugs of abuse testing, i.e., analysis of biological specimens to detect drug intake or exposure, has seen significant developments recently. Technological advances in rapid testing devices have prompted a shift from laboratory-based examinations to on-site testing, enhancing the speed, privacy, and convenience for users. Despite...
Discover more insightsThe drug testing market has witnessed a robust growth driven by several key factors. Primarily, a proactive initiative by employers to identify and address drug abuse is contributing to the increased demand for drug testing. In addition, an escalating global issue of substance abuse pushes nations to adopt stringent regulations,...
Discover more insightsThe healthcare diagnostics landscape has been witnessing significant evolution, driven by both market and technological factors. One area that has seen considerable change is the segment involving amphetamines testing. With the prevalence of substance abuse disorders on the rise, demand for effective and efficient amphetamines testing has experienced a parallel...
Discover more insightsBenzodiazepines, which are used to treat a variety of conditions like anxiety disorders, sleep issues and seizures, undergo testing both to determine efficiency in patients and to monitor potential abuse. However, due to evolving regulations and changes in healthcare policy, the volume of these tests has fluctuated over time. Recently,...
Discover more insightsIn the realm of healthcare, the trajectory of LSD test volume and sales is of genuine interest. While it was a relatively obscure segment earlier, this specialty has been catapulted into limelight due to the emergence of novel drugs and increasing sensitivity towards mental health disorders, including addiction. Responding to...
Discover more insightsIn recent years, there has been a steady increase in methadone testing, prompted by the rising global concern over opioid abuse and the subsequent need for treatment and management. Methadone, being a synthetic opioid, is often subject to regular testing to monitor adherence to treatment protocols, potential diversion, and any...
Discover more insightsOver the last few years, the market for Methaqualone testing has expanded robustly, driven by a combination of medical advancements, improved lab technologies, and an increase in regulatory policies related to drug abuse surveillance. As illegal use of this substance prevails globally, healthcare sectors are compelled to participate actively in...
Discover more insightsThe healthcare sector is experiencing significant shifts in its landscape due to the increasing prevalence of Phencyclidine (PCP) abuse, necessitating a deeper exploration of test volume and sales dynamics. The growth trajectory for tests and sales is propelled by the rising awareness about the harmful effects of PCP, alongside improved...
Discover more insightsThe urinalysis tests industry is being significantly influenced by rapid technological developments, especially the adoption of automated systems and artificial intelligence. Coupled with ever-growing health awareness, it triggers a considerable surge in the demand for these tests. Rising incidence of kidney diseases and urinary tract infections also fundamentally contributes to...
Discover more insightsThe screening examinations industry is spearheaded by a couple of key drivers. Firstly, an increase in the prevalence of chronic diseases and the resultant rise in health awareness has led to a surge in demand for routine tests. Secondly, the progression towards preventive healthcare is significantly contributing to the growth...
Discover more insights